[关键词]
[摘要]
目的 探讨传统中药蟾酥逆转人白血病K562/DOX细胞多药耐药性(MDR)的作用。方法 采用中药血清药理学方法制备蟾酥含药血清,以MTT法分别检测蟾酥含药血清联合柔红霉素,或单用蟾酥含药血清处理后,不同时段作用于K562/DOX细胞的抑制率;实时荧光定量PCR法检测蟾酥含药血清对K562/DOX细胞的Bcl-2 mRNA表达。结果 与空白对照组比较,蟾酥对K562/DOX细胞均有抑制作用;蟾酥组Bcl-2 mRNA表达降低。结论 蟾酥可能通过下调MDR1表达水平进而逆转K562/DOX细胞的耐药性。
[Key word]
[Abstract]
Objective To explore the effect of Venenum Bufonis on reversing the multidrug resistance of human leukemia cell line K562/DOX. Methods Serum containing Venenum Bufonis was prepared firstly,and then was applied alone or together with Daunorubicin for the culture of human leukemia cell line K562/DOX. After treatment for some time,the inhibition ratio of K562/DOX was detected by MTT assay,and Bcl-2 mRNA expression in K562/DOX was examined by real-time fluorescent quantitation PCR. Results In comparison with the control group,Venenum Bufonis had an inhibition on K562/DOX and decreased the Bcl-2 mRNA expression. Conclusion Venenum Bufonis can down-regulate the MDR1 expression level,and thus reverse the multidrug resistance of human leukemia cell line K562/DOX.
[中图分类号]
R285.5
[基金项目]
广东省中医药管理局资助项目(20121216);广东省科技发展计划资助项目(2012b03180019)。